Stockscreener 앱 받기
2.97
1.66%
-0.05
시장 영업 전:
2.98
0.010
+0.34%
Puma Biotechnology Inc 주식(PBYI)의 최신 뉴스
Is Now The Time To Put Puma Biotechnology (NASDAQ:PBYI) On Your Watchlist? - Yahoo Finance
Jane Street Group LLC Buys 16,374 Shares of Puma Biotechnology, Inc. (NASDAQ:PBYI) - Defense World
Insufficient Growth At Puma Biotechnology, Inc. (NASDAQ:PBYI) Hampers Share Price - Simply Wall St
Zacks Research Has Negative Outlook of PBYI FY2024 Earnings - MarketBeat
Zacks Research Issues Pessimistic Estimate for PBYI Earnings - Defense World
FY2025 EPS Forecast for Puma Biotechnology Raised by Analyst - Defense World
FY2025 EPS Estimate for Puma Biotechnology Lifted by Analyst - MarketBeat
PBYI Begins Phase II Study on Alisertib Combo in Breast Cancer - MSN
Geode Capital Management LLC Has $2.34 Million Holdings in Puma Biotechnology, Inc. (NASDAQ:PBYI) - Defense World
Barclays PLC Buys 46,370 Shares of Puma Biotechnology, Inc. (NASDAQ:PBYI) - Defense World
Best Momentum Stocks to Buy for January 6th - Yahoo Finance
Puma Biotechnology CEO Alan Auerbach sells $106,656 in stock By Investing.com - Investing.com Australia
Puma Biotechnology's SVP sells $27,208 in stock By Investing.com - Investing.com South Africa
Puma Biotechnology chief commercial officer sells $29,742 in stock By Investing.com - Investing.com Australia
Puma Biotechnology chief commercial officer sells $29,742 in stock - Investing.com India
Puma Biotechnology, Inc. (NASDAQ:PBYI) Insider Jeffrey Jerome Ludwig Sells 9,437 Shares - MarketBeat
Alan H. Auerbach Sells 33,841 Shares of Puma Biotechnology, Inc. (NASDAQ:PBYI) Stock - MarketBeat
Puma Biotechnology’s SVP sells $27,208 in stock By Investing.com - Investing.com Nigeria
Puma Biotechnology CFO sells shares worth $32,232 By Investing.com - Investing.com Australia
Puma Biotechnology CFO sells shares worth $32,232 - Investing.com
Puma Biotechnology's SVP sells $27,208 in stock - Investing.com
Puma Biotechnology CEO Alan Auerbach sells $106,656 in stock - Investing.com
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Franklin Resources Inc. Invests $41,000 in Puma Biotechnology, Inc. (NASDAQ:PBYI) - Defense World
State Street Corp Has $1.53 Million Stake in Puma Biotechnology, Inc. (NASDAQ:PBYI) - Defense World
Is Puma Biotechnology (PBYI) Stock Undervalued Right Now? - MSN
All You Need to Know About Puma Biotech (PBYI) Rating Upgrade to Strong Buy - Yahoo Finance
Puma Biotechnology Stock Rises 24% in 3 Months: Here's Why - MSN
Puma biotechnology sales earnings call - Ciudad Florida
Research Analysts Set Expectations for PBYI FY2025 Earnings - Defense World
What Every Investor Should Know: Understanding ROE Can Change Your Game! - Clinique Bio
Best Value Stocks to Buy for December 24th - MSN
Zacks Research Has Positive Outlook of PBYI FY2025 Earnings - MarketBeat
Should You Be Excited About Puma Biotechnology, Inc.'s (NASDAQ:PBYI) 33% Return On Equity? - Simply Wall St
Puma Biotech shares hold as analyst backs Buy rating on NCCN nod - Investing.com Canada
Puma Biotechnology (NASDAQ:PBYI) Given “Buy” Rating at HC Wainwright - Defense World
Best Momentum Stocks To Buy For December 24th - Barchart
Best Momentum Stocks to Buy for December 24th - Yahoo Finance
With 49% stake, Puma Biotechnology, Inc. (NASDAQ:PBYI) seems to have captured institutional investors' interest - Yahoo Finance
Puma Biotechnology's (PBYI) Buy Rating Reaffirmed at HC Wainwright - MarketBeat
Included in NCCN Clinical Practice Guidelines for the Treatment of Cervical Cancer with a HER2 Mutation - Business Wire
XTX Topco Ltd Sells 22,227 Shares of Puma Biotechnology, Inc. (NASDAQ:PBYI) - Defense World
Puma Biotechnology, Inc. (NASDAQ:PBYI) Shares Acquired by Fmr LLC - Defense World
Puma Biotechnology: The Best Performing Biotechs of 2013 - AOL
Charles Schwab Investment Management Inc. Sells 8,574 Shares of Puma Biotechnology, Inc. (NASDAQ:PBYI) - Defense World
Puma Biotechnology, Inc. (NASDAQ:PBYI) Shares Bought by BNP Paribas Financial Markets - Defense World
Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock? - Yahoo Finance
Puma biotechnologies 2025 - detikawanua.com
Puma Biotechnology: Continuing To Push Their Aurora Kinase Story Forward - Seeking Alpha
Puma Biotechnology (NASDAQ:PBYI) Lowered to Buy Rating by StockNews.com - MarketBeat
0.65%
4.62%
자본화:
|
볼륨(24시간):